| Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values R Rolke, R Baron, C Maier, TR Tölle, RD Treede, A Beyer, A Binder, ... Pain® 123 (3), 231-243, 2006 | 2690 | 2006 |
| Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes C Maier, R Baron, TR Tölle, A Binder, N Birbaumer, F Birklein, ... Pain 150 (3), 439-450, 2010 | 1091 | 2010 |
| Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data SJ Tabrizi, DR Langbehn, BR Leavitt, RAC Roos, A Durr, D Craufurd, ... The Lancet Neurology 8 (9), 791-801, 2009 | 1032 | 2009 |
| Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data SJ Tabrizi, RI Scahill, G Owen, A Durr, BR Leavitt, RA Roos, B Borowsky, ... The Lancet Neurology 12 (7), 637-649, 2013 | 912 | 2013 |
| Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis SJ Tabrizi, RI Scahill, A Durr, RAC Roos, BR Leavitt, R Jones, ... The Lancet Neurology 10 (1), 31-42, 2011 | 650 | 2011 |
| Targeting huntingtin expression in patients with Huntington’s disease SJ Tabrizi, BR Leavitt, GB Landwehrmeyer, EJ Wild, C Saft, RA Barker, ... New England Journal of Medicine 380 (24), 2307-2316, 2019 | 641 | 2019 |
| A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease H Goehler, M Lalowski, U Stelzl, S Waelter, M Stroedicke, U Worm, ... Molecular cell 15 (6), 853-865, 2004 | 601 | 2004 |
| Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis W Van Rheenen, A Shatunov, AM Dekker, RL McLaughlin, FP Diekstra, ... Nature genetics 48 (9), 1043-1048, 2016 | 590 | 2016 |
| Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data SJ Tabrizi, R Reilmann, RAC Roos, A Durr, B Leavitt, G Owen, R Jones, ... The Lancet Neurology 11 (1), 42-53, 2012 | 585 | 2012 |
| Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions A Lunkes, KS Lindenberg, L Ben-Haı̈em, C Weber, D Devys, ... Molecular cell 10 (2), 259-269, 2002 | 494 | 2002 |
| Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain AT Bruinvels, B Landwehrmeyer, EL Gustafson, MM Durkin, G Mengod, ... Neuropharmacology 33 (3-4), 367-386, 1994 | 423 | 1994 |
| CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion JM Lee, EM Ramos, JH Lee, T Gillis, JS Mysore, MR Hayden, SC Warby, ... Neurology 78 (10), 690-695, 2012 | 420 | 2012 |
| Transgenic rat model of Huntington's disease S von Hörsten, I Schmitt, HP Nguyen, C Holzmann, T Schmidt, T Walther, ... Human molecular genetics 12 (6), 617-624, 2003 | 418 | 2003 |
| Identification of genetic factors that modify clinical onset of Huntington’s disease JM Lee, VC Wheeler, MJ Chao, JPG Vonsattel, RM Pinto, D Lucente, ... Cell 162 (3), 516-526, 2015 | 411 | 2015 |
| Impaired glutamate transport and glutamate–glutamine cycling: downstream effects of the Huntington mutation PF Behrens, P Franz, B Woodman, KS Lindenberg, GB Landwehrmeyer Brain 125 (8), 1908-1922, 2002 | 388 | 2002 |
| NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum GB Landwehrmeyer, DG Standaert, CM Testa, JB Penney, AB Young Journal of Neuroscience 15 (7), 5297-5307, 1995 | 365 | 1995 |
| Weight loss in Huntington disease increases with higher CAG repeat number NA Aziz, JMM van der Burg, GB Landwehrmeyer, P Brundin, T Stijnen, ... Neurology 71 (19), 1506-1513, 2008 | 357 | 2008 |
| Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy RG Brown, L Lacomblez, BG Landwehrmeyer, T Bak, I Uttner, B Dubois, ... Brain 133 (8), 2382-2393, 2010 | 337 | 2010 |
| Topography of cerebral atrophy in early Huntington’s disease: a voxel based morphometric MRI study J Kassubek, FD Juengling, T Kioschies, K Henkel, J Karitzky, B Kramer, ... Journal of Neurology, Neurosurgery & Psychiatry 75 (2), 213-220, 2004 | 333 | 2004 |
| Expression of mu, kappa, and delta opioid receptor messenger RNA in the human CNS: a 33P in situ hybridization study D Peckys, GB Landwehrmeyer Neuroscience 88 (4), 1093-1135, 1999 | 333 | 1999 |
